The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Hippocrates Research; Ipsen; MSD Oncology; SERVIER; Viatris
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; MSD Oncology
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Novartis; Novartis; Oncosil
Implementing precision oncology in renal cell carcinoma (RCC): Prospective identification of clinical, tissue-based, and circulating factors to refine outcome prediction and support therapeutic choices (SIGNS-RCC TRIAL).
 
Ilaria Zampiva
Travel, Accommodations, Expenses - Ipsen; Merck
 
Emanuela Fantinel
Consulting or Advisory Role - AstraZeneca; Bayer
Speakers' Bureau - Astellas Oncology; MSD
Travel, Accommodations, Expenses - Ipsen; Janssen; Pfizer
 
Veronica Mollica
No Relationships to Disclose
 
Sara Elena Rebuzzi
No Relationships to Disclose
 
Davide Bimbatti
Consulting or Advisory Role - Ipsen; MSD
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; MSD
 
Francesca Bertolotti
No Relationships to Disclose
 
Matteo Brunelli
No Relationships to Disclose
 
Stefano Manduca
No Relationships to Disclose
 
Pierpaolo Marchetti
No Relationships to Disclose
 
Andrea Marchetti
No Relationships to Disclose
 
Jessica Menis
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Novartis
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Pfizer; MSD Oncology; Novartis; Roche
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; MSD Oncology
 
Guido Martignoni
No Relationships to Disclose
 
Cecilia Nasso
No Relationships to Disclose
 
Michela Piacentini
No Relationships to Disclose
 
Francesco Pierantoni
No Relationships to Disclose
 
Matteo Rosellini
No Relationships to Disclose
 
Giuseppe Verlato
No Relationships to Disclose
 
Roberta Vesentini
No Relationships to Disclose
 
Michele Milella
No Relationships to Disclose
 
Anna Caliò
No Relationships to Disclose